About Brian

Brian McMahon is a clinical Hepatologist, Medical, and Research Director at the Liver Disease and Viral Hepatitis Program at Alaska Native Medical Center. He coordinated programs to eradicate transmission hepatitis B (HBV) and hepatitis A (HAV) in the Alaska Native Population. He and his colleagues conduct research in the outcome and treatment of HBV, hepatitis C (HCV) and long-term protection of HAV and HBV vaccines. He is Clinical Professor of Medicine at University of Washington and an Auxiliary Professor at the University of Alaska WWAMI Medical Schools He was co author of the AASLD Practice Guideline on Chronic Hepatitis B 2001 to 2009, on the methodology committee for the 2016 AASLD Guidelines and the writing committee for the 2017 AASLD supplemental Guideline. He was co-chair of the WHO hepatitis B Guidelines Committee. He has also participated in establishing model programs for management of HBV/HIV co-infection and HBV monoinfection with the CDC Foundation since 2008.

This speaker will be presenting at the following session(s)

  • Delivering high quality hepatitis services

    Parallel workshop

    Day: 2 November

    Time: 11:30

    Presentations:

    • Australia service delivery model.
    • Professor Margaret Hellard, Burnet Institute, The Alfred Hospital and Monash University
    • HCV testing, treatment and care of people who inject drugs: lessons from Georgia, Kenya and Vietnam.
    • Abigael Lukhwaro, Médecins du Monde
    • Ukraine case study.
    • HBV diagnostics and indigenous people in Alaska.
    • Dr. Brian McMahon, Alaska Native Tribal Health Consortium

    Session objectives:

    • Review examples of service delivery models for different population groups.
    • Discuss gaps in HBV vaccination, HBV and HCV testing, diagnosis, treatment and care cascade for key populations in different settings and possible solutions to filling in the gaps.
    • Assess the role of case management; peer-to-peer support in community-based or community oriented service delivery.
  • Liver societies’ role towards global elimination of hepatitis

    Side meeting

    Day: 2 November

    Time: 07:30

    Presented by AASLD, EASL and ALEH, this early morning side meeting will look at the role of the professional medical societies in the viral hepatitis elimination plan.